Medication Considerations
Provide information or materials on the three medications approved by the Food and Drug Administration to treat opioid use disorder.
Quick Guide: MAT Use for Alcohol Use Disorder
This guide outlines the three Food and Drug Administration (FDA)-approved medications for opioid use disorder, including common brands, how they work, things to consider before prescribing, and questions to ask patients before prescribing it.
Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes
Medicines To Treat Alcohol Use Disorder: Consumer Summary
MAT Resources for FQHC Providers
This web page includes resources and documents to support providers in Federally Qualified Health Centers (FQHC) with implementing medications for substance use treatment. It includes sample workflows and templates, patient treatment agreements, clinical tools, procedures, and policies.
MAT Medications, Counseling, and Related Conditions
This web page displays information and resources about medication-assisted treatment (MAT) for substance use disorders, including most commonly used medicines and behavioral therapies.
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
This systematic review synthesizes the literature on behavioral, pharmacologic, and combined interventions for adolescents ages 12 to 20 years with problematic substance use or substance use disorder.
How to Integrate Pharmacotherapy for Substance Use Disorders at Your Mental Health Clinic
This toolkit provides a step-by-step guide for introducing pharmacotherapy for co-occurring mental health and substance use disorders, including a workflow map and roles and responsibilities for all team members, including primary care.
How Do You Effectively Evaluate the Elderly for Alcohol Use Disorder?
Getting Paid for MAT: Sustainable Reimbursement Series
This webinar series includes resources and trainings related to administering and reimbursement for medications for addiction treatment, including reimbursement for telehealth for substance use disorders.
Pagination
- Previous page
- Page 9
- Next page